Drug intelligence / Profile preview

omega-3 fish oil

Development stage
Unknown
Lead developer
University of Virginia
Modality
Small Molecules
Administration
Oral
01

Overview

Omega-3 fish oil is a dietary supplement derived from fatty fish that contains long-chain polyunsaturated fatty acids, specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). In the context of non-alcoholic steatohepatitis (NASH), these fatty acids are investigated for their potential to improve hepatic histological injury by modulating lipid metabolism and reducing inflammation. The University of Virginia conducted a Phase 2/3 randomized, placebo-controlled trial evaluating a 3,000 mg/day dose of omega-3 fish oil over 12 months. While the study did not meet its primary endpoint of significant reduction in the NASH Activity Score (NAS), it demonstrated significant fat reduction on image-assisted morphometry and reduced liver fat content by MRI in specific patient subgroups.

Other names
fish oilomega-3 fatty acidsomega3 fatty acidsomega 3 fatty acidsEPA + DHAeicosapentaenoic acid + docosahexaenoic acidomega 3 fish oil-University of Virginia-non-alcoholic steatohepatitisomega3 fish oil-University of Virginia-non-alcoholic steatohepatitisomega-3 fish oil-University of Virginia-non-alcoholic steatohepatitis
02

Targets

PPARA (Peroxisome proliferator-activated receptor alpha)SREBP-1 / SREBF1 (SREBP-1)FFAR4 (Free fatty acid receptor 4)

Beyond the preview

Go deeper on omega-3 fish oil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on omega-3 fish oil.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call